Safety and efficacy of Profermin® to induce remission in ulcerative colitis

Table 2 Description of four excluded patients and eight dropouts

Day	SCCAI run in	Reason for discontinuation	SCCAI dropout	Reduction	Increase
Excluded patients
10	8.9	1	6.6	2.3
45	8.0	1	4.1	3.9
100	8.2	1	4.1	4.1
116	11	2	3.6	7.4
Drop-outs
9	8.9	3	6.7	2.2
54	4.6	3	5.1		0.5
73	5.9	3	7.3		1.4
100	5.6	3	8.4		2.8
102	9.0	3	6.7	2.3
127	6.6	3	5.6	1.0
140	6.7	3	5.3	1.4
141	8.3	3	6.3	2.0

Reasons for discontinuation in the study. 1: Excluded because of new medication prescribed for unrelated diseases; 2: Excluded because of new medication prescribed for colitis; 3: Dropouts main reason: Not satisfied with effect of treatment. SCCAI: Simple Clinical Colitis Activity Index.